At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Hypertension
Most Recent Events
- 14 Oct 1994 Discontinued-Preclinical for Arrhythmias in Hong Kong (Unknown route)
- 14 Oct 1994 Discontinued-Preclinical for Hypertension (Unknown route)